nodes	percent_of_prediction	percent_of_DWPC	metapath
Leucovorin—Methotrexate—colon cancer	0.333	1	CrCtD
Leucovorin—TYMS—colon cancer	0.188	1	CbGaD
Leucovorin—TYMS—Capecitabine—colon cancer	0.0666	0.295	CbGbCtD
Leucovorin—Pralatrexate—Methotrexate—colon cancer	0.0441	0.2	CrCrCtD
Leucovorin—Raltitrexed—Methotrexate—colon cancer	0.0441	0.2	CrCrCtD
Leucovorin—Pemetrexed—Methotrexate—colon cancer	0.0441	0.2	CrCrCtD
Leucovorin—Folic Acid—Methotrexate—colon cancer	0.0441	0.2	CrCrCtD
Leucovorin—Tetrahydrofolic acid—Methotrexate—colon cancer	0.0441	0.2	CrCrCtD
Leucovorin—TYMS—Fluorouracil—colon cancer	0.0395	0.175	CbGbCtD
Leucovorin—TYMS—Methotrexate—colon cancer	0.0218	0.0964	CbGbCtD
Leucovorin—ABCC3—Fluorouracil—colon cancer	0.0205	0.0907	CbGbCtD
Leucovorin—ABCC3—Vincristine—colon cancer	0.0186	0.0826	CbGbCtD
Leucovorin—ABCC4—Fluorouracil—colon cancer	0.0156	0.0693	CbGbCtD
Leucovorin—ABCC3—Methotrexate—colon cancer	0.0113	0.05	CbGbCtD
Leucovorin—ABCC2—Irinotecan—colon cancer	0.00969	0.0429	CbGbCtD
Leucovorin—ABCC4—Methotrexate—colon cancer	0.00862	0.0382	CbGbCtD
Leucovorin—ABCC2—Vincristine—colon cancer	0.00847	0.0375	CbGbCtD
Leucovorin—ABCC2—Methotrexate—colon cancer	0.00513	0.0227	CbGbCtD
Leucovorin—ABCC2—bile—colon cancer	0.00206	0.264	CbGeAlD
Leucovorin—Caecitis—Irinotecan—colon cancer	0.00203	0.107	CcSEcCtD
Leucovorin—ABCC3—gall bladder—colon cancer	0.000715	0.0917	CbGeAlD
Leucovorin—Raltitrexed—TYMS—colon cancer	0.000583	0.359	CrCbGaD
Leucovorin—Abdominal pain lower—Capecitabine—colon cancer	0.000535	0.0282	CcSEcCtD
Leucovorin—Pralatrexate—TYMS—colon cancer	0.000442	0.272	CrCbGaD
Leucovorin—TYMS—Vinorelbine—Vincristine—colon cancer	0.000438	0.593	CbGdCrCtD
Leucovorin—TYMS—smooth muscle tissue—colon cancer	0.000435	0.0557	CbGeAlD
Leucovorin—Febrile neutropenia—Vincristine—colon cancer	0.000434	0.0228	CcSEcCtD
Leucovorin—Febrile neutropenia—Irinotecan—colon cancer	0.000422	0.0222	CcSEcCtD
Leucovorin—Serum creatinine increased—Irinotecan—colon cancer	0.000413	0.0217	CcSEcCtD
Leucovorin—Febrile neutropenia—Fluorouracil—colon cancer	0.000404	0.0213	CcSEcCtD
Leucovorin—Pemetrexed—TYMS—colon cancer	0.000353	0.218	CrCbGaD
Leucovorin—TYMS—lymphoid tissue—colon cancer	0.000347	0.0446	CbGeAlD
Leucovorin—TYMS—digestive system—colon cancer	0.000343	0.044	CbGeAlD
Leucovorin—ABCC3—renal system—colon cancer	0.000343	0.044	CbGeAlD
Leucovorin—ABCC3—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000333	0.0827	CbGpPWpGaD
Leucovorin—TYMS—bone marrow—colon cancer	0.000316	0.0406	CbGeAlD
Leucovorin—TYMS—vagina—colon cancer	0.000303	0.0389	CbGeAlD
Leucovorin—TYMS—Vinblastine—Vincristine—colon cancer	0.000301	0.407	CbGdCrCtD
Leucovorin—Extravasation—Vincristine—colon cancer	0.000299	0.0157	CcSEcCtD
Leucovorin—Extravasation—Irinotecan—colon cancer	0.000291	0.0153	CcSEcCtD
Leucovorin—ABCC4—renal system—colon cancer	0.000283	0.0363	CbGeAlD
Leucovorin—Febrile neutropenia—Capecitabine—colon cancer	0.000283	0.0149	CcSEcCtD
Leucovorin—ABCC3—digestive system—colon cancer	0.000281	0.0361	CbGeAlD
Leucovorin—Extravasation—Fluorouracil—colon cancer	0.000279	0.0147	CcSEcCtD
Leucovorin—Serum creatinine increased—Capecitabine—colon cancer	0.000276	0.0146	CcSEcCtD
Leucovorin—ABCC2—renal system—colon cancer	0.000274	0.0352	CbGeAlD
Leucovorin—ABCC2—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000264	0.0656	CbGpPWpGaD
Leucovorin—TYMS—liver—colon cancer	0.000256	0.0328	CbGeAlD
Leucovorin—Neuropathy—Vincristine—colon cancer	0.000245	0.0129	CcSEcCtD
Leucovorin—ABCC4—digestive system—colon cancer	0.000232	0.0298	CbGeAlD
Leucovorin—ABCC2—digestive system—colon cancer	0.000225	0.0288	CbGeAlD
Leucovorin—ABCC4—bone marrow—colon cancer	0.000214	0.0275	CbGeAlD
Leucovorin—Febrile neutropenia—Methotrexate—colon cancer	0.00021	0.0111	CcSEcCtD
Leucovorin—ABCC3—liver—colon cancer	0.00021	0.0269	CbGeAlD
Leucovorin—Rigors—Capecitabine—colon cancer	0.000208	0.011	CcSEcCtD
Leucovorin—Renal failure acute—Irinotecan—colon cancer	0.0002	0.0105	CcSEcCtD
Leucovorin—TYMS—lymph node—colon cancer	0.000196	0.0251	CbGeAlD
Leucovorin—Methotrexate—TYMS—colon cancer	0.000195	0.12	CrCbGaD
Leucovorin—Renal impairment—Irinotecan—colon cancer	0.000194	0.0102	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Irinotecan—colon cancer	0.000191	0.01	CcSEcCtD
Leucovorin—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000182	0.0453	CbGpPWpGaD
Leucovorin—Lethargy—Fluorouracil—colon cancer	0.00018	0.00949	CcSEcCtD
Leucovorin—ABCC4—liver—colon cancer	0.000173	0.0222	CbGeAlD
Leucovorin—Blood creatinine increased—Irinotecan—colon cancer	0.000173	0.0091	CcSEcCtD
Leucovorin—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000171	0.0426	CbGpPWpGaD
Leucovorin—ABCC2—liver—colon cancer	0.000168	0.0215	CbGeAlD
Leucovorin—ABCC3—lymph node—colon cancer	0.000161	0.0206	CbGeAlD
Leucovorin—Neuropathy—Capecitabine—colon cancer	0.00016	0.00841	CcSEcCtD
Leucovorin—Extravasation—Methotrexate—colon cancer	0.000145	0.00764	CcSEcCtD
Leucovorin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000145	0.0359	CbGpPWpGaD
Leucovorin—Neuropathy peripheral—Vincristine—colon cancer	0.000143	0.00753	CcSEcCtD
Leucovorin—Stomatitis—Vincristine—colon cancer	0.000142	0.00749	CcSEcCtD
Leucovorin—Stomatitis—Irinotecan—colon cancer	0.000139	0.00729	CcSEcCtD
Leucovorin—Renal failure acute—Capecitabine—colon cancer	0.000134	0.00704	CcSEcCtD
Leucovorin—Neuropathy peripheral—Fluorouracil—colon cancer	0.000133	0.00703	CcSEcCtD
Leucovorin—ABCC4—lymph node—colon cancer	0.000133	0.017	CbGeAlD
Leucovorin—Stomatitis—Fluorouracil—colon cancer	0.000133	0.00699	CcSEcCtD
Leucovorin—Renal impairment—Capecitabine—colon cancer	0.00013	0.00683	CcSEcCtD
Leucovorin—ABCC2—lymph node—colon cancer	0.000128	0.0165	CbGeAlD
Leucovorin—Lethargy—Capecitabine—colon cancer	0.000126	0.00663	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MSH6—colon cancer	0.000123	0.0305	CbGpPWpGaD
Leucovorin—ABCC2—Irinotecan Pathway—APC—colon cancer	0.000122	0.0302	CbGpPWpGaD
Leucovorin—Alopecia—Vincristine—colon cancer	0.000116	0.0061	CcSEcCtD
Leucovorin—Blood creatinine increased—Capecitabine—colon cancer	0.000116	0.00609	CcSEcCtD
Leucovorin—Chills—Irinotecan—colon cancer	0.000114	0.00603	CcSEcCtD
Leucovorin—Alopecia—Irinotecan—colon cancer	0.000113	0.00594	CcSEcCtD
Leucovorin—Abdominal pain upper—Capecitabine—colon cancer	0.000113	0.00594	CcSEcCtD
Leucovorin—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00011	0.0273	CbGpPWpGaD
Leucovorin—Alopecia—Fluorouracil—colon cancer	0.000108	0.00569	CcSEcCtD
Leucovorin—Erythema—Fluorouracil—colon cancer	0.000106	0.0056	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TYMS—colon cancer	0.000105	0.0262	CbGpPWpGaD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000105	0.026	CbGpPWpGaD
Leucovorin—Ill-defined disorder—Irinotecan—colon cancer	0.000103	0.00543	CcSEcCtD
Leucovorin—Leukopenia—Vincristine—colon cancer	0.000102	0.00538	CcSEcCtD
Leucovorin—Malaise—Irinotecan—colon cancer	0.0001	0.00527	CcSEcCtD
Leucovorin—ABCC3—ABC-family proteins mediated transport—ABCB1—colon cancer	0.0001	0.0248	CbGpPWpGaD
Leucovorin—Syncope—Irinotecan—colon cancer	9.96e-05	0.00524	CcSEcCtD
Leucovorin—Renal failure acute—Methotrexate—colon cancer	9.95e-05	0.00524	CcSEcCtD
Leucovorin—Leukopenia—Irinotecan—colon cancer	9.94e-05	0.00523	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TYMS—colon cancer	9.9e-05	0.0246	CbGpPWpGaD
Leucovorin—Convulsion—Vincristine—colon cancer	9.88e-05	0.0052	CcSEcCtD
Leucovorin—Loss of consciousness—Irinotecan—colon cancer	9.76e-05	0.00514	CcSEcCtD
Leucovorin—Leukopenia—Fluorouracil—colon cancer	9.52e-05	0.00501	CcSEcCtD
Leucovorin—Anaphylactoid reaction—Methotrexate—colon cancer	9.49e-05	0.005	CcSEcCtD
Leucovorin—ABCC4—ABC-family proteins mediated transport—ABCB1—colon cancer	9.41e-05	0.0234	CbGpPWpGaD
Leucovorin—Lethargy—Methotrexate—colon cancer	9.38e-05	0.00494	CcSEcCtD
Leucovorin—Discomfort—Irinotecan—colon cancer	9.34e-05	0.00492	CcSEcCtD
Leucovorin—Neuropathy peripheral—Capecitabine—colon cancer	9.32e-05	0.00491	CcSEcCtD
Leucovorin—Anaphylactic shock—Vincristine—colon cancer	9.31e-05	0.0049	CcSEcCtD
Leucovorin—Stomatitis—Capecitabine—colon cancer	9.27e-05	0.00488	CcSEcCtD
Leucovorin—Infection—Vincristine—colon cancer	9.25e-05	0.00487	CcSEcCtD
Leucovorin—Convulsion—Fluorouracil—colon cancer	9.22e-05	0.00485	CcSEcCtD
Leucovorin—Confusional state—Irinotecan—colon cancer	9.14e-05	0.00481	CcSEcCtD
Leucovorin—Thrombocytopenia—Vincristine—colon cancer	9.11e-05	0.0048	CcSEcCtD
Leucovorin—Anaphylactic shock—Irinotecan—colon cancer	9.06e-05	0.00477	CcSEcCtD
Leucovorin—Infection—Irinotecan—colon cancer	9e-05	0.00474	CcSEcCtD
Leucovorin—Discomfort—Fluorouracil—colon cancer	8.95e-05	0.00471	CcSEcCtD
Leucovorin—Shock—Irinotecan—colon cancer	8.92e-05	0.0047	CcSEcCtD
Leucovorin—Thrombocytopenia—Irinotecan—colon cancer	8.87e-05	0.00467	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	8.87e-05	0.022	CbGpPWpGaD
Leucovorin—Anorexia—Vincristine—colon cancer	8.87e-05	0.00467	CcSEcCtD
Leucovorin—Confusional state—Fluorouracil—colon cancer	8.75e-05	0.00461	CcSEcCtD
Leucovorin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	8.71e-05	0.0216	CbGpPWpGaD
Leucovorin—Anaphylactic shock—Fluorouracil—colon cancer	8.68e-05	0.00457	CcSEcCtD
Leucovorin—Anorexia—Irinotecan—colon cancer	8.64e-05	0.00455	CcSEcCtD
Leucovorin—Infection—Fluorouracil—colon cancer	8.62e-05	0.00454	CcSEcCtD
Leucovorin—TYMS—Circadian rythm related genes—TOP1—colon cancer	8.52e-05	0.0212	CbGpPWpGaD
Leucovorin—Thrombocytopenia—Fluorouracil—colon cancer	8.5e-05	0.00448	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	8.3e-05	0.0206	CbGpPWpGaD
Leucovorin—Anorexia—Fluorouracil—colon cancer	8.27e-05	0.00436	CcSEcCtD
Leucovorin—Decreased appetite—Vincristine—colon cancer	8.09e-05	0.00426	CcSEcCtD
Leucovorin—Dyspnoea—Irinotecan—colon cancer	8.08e-05	0.00426	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Vincristine—colon cancer	8.03e-05	0.00423	CcSEcCtD
Leucovorin—Fatigue—Vincristine—colon cancer	8.02e-05	0.00423	CcSEcCtD
Leucovorin—Dyspepsia—Irinotecan—colon cancer	7.98e-05	0.0042	CcSEcCtD
Leucovorin—Constipation—Vincristine—colon cancer	7.96e-05	0.00419	CcSEcCtD
Leucovorin—ABCC2—ABC-family proteins mediated transport—ABCB1—colon cancer	7.93e-05	0.0197	CbGpPWpGaD
Leucovorin—Decreased appetite—Irinotecan—colon cancer	7.88e-05	0.00415	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Irinotecan—colon cancer	7.82e-05	0.00412	CcSEcCtD
Leucovorin—Fatigue—Irinotecan—colon cancer	7.81e-05	0.00411	CcSEcCtD
Leucovorin—Constipation—Irinotecan—colon cancer	7.75e-05	0.00408	CcSEcCtD
Leucovorin—Dyspnoea—Fluorouracil—colon cancer	7.74e-05	0.00408	CcSEcCtD
Leucovorin—Chills—Capecitabine—colon cancer	7.66e-05	0.00403	CcSEcCtD
Leucovorin—Dyspepsia—Fluorouracil—colon cancer	7.64e-05	0.00402	CcSEcCtD
Leucovorin—Gastrointestinal pain—Vincristine—colon cancer	7.61e-05	0.00401	CcSEcCtD
Leucovorin—Decreased appetite—Fluorouracil—colon cancer	7.55e-05	0.00397	CcSEcCtD
Leucovorin—Alopecia—Capecitabine—colon cancer	7.54e-05	0.00397	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Fluorouracil—colon cancer	7.49e-05	0.00395	CcSEcCtD
Leucovorin—Feeling abnormal—Irinotecan—colon cancer	7.47e-05	0.00393	CcSEcCtD
Leucovorin—Erythema—Capecitabine—colon cancer	7.43e-05	0.00391	CcSEcCtD
Leucovorin—Gastrointestinal pain—Irinotecan—colon cancer	7.41e-05	0.0039	CcSEcCtD
Leucovorin—Body temperature increased—Vincristine—colon cancer	7.36e-05	0.00387	CcSEcCtD
Leucovorin—Abdominal pain—Vincristine—colon cancer	7.36e-05	0.00387	CcSEcCtD
Leucovorin—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	7.29e-05	0.0181	CbGpPWpGaD
Leucovorin—Dysgeusia—Capecitabine—colon cancer	7.28e-05	0.00383	CcSEcCtD
Leucovorin—Body temperature increased—Irinotecan—colon cancer	7.16e-05	0.00377	CcSEcCtD
Leucovorin—Abdominal pain—Irinotecan—colon cancer	7.16e-05	0.00377	CcSEcCtD
Leucovorin—Feeling abnormal—Fluorouracil—colon cancer	7.15e-05	0.00377	CcSEcCtD
Leucovorin—Stomatitis—Methotrexate—colon cancer	6.9e-05	0.00363	CcSEcCtD
Leucovorin—Ill-defined disorder—Capecitabine—colon cancer	6.9e-05	0.00363	CcSEcCtD
Leucovorin—Urticaria—Fluorouracil—colon cancer	6.9e-05	0.00363	CcSEcCtD
Leucovorin—Body temperature increased—Fluorouracil—colon cancer	6.86e-05	0.00361	CcSEcCtD
Leucovorin—Hypersensitivity—Vincristine—colon cancer	6.86e-05	0.00361	CcSEcCtD
Leucovorin—Malaise—Capecitabine—colon cancer	6.7e-05	0.00353	CcSEcCtD
Leucovorin—Hypersensitivity—Irinotecan—colon cancer	6.68e-05	0.00352	CcSEcCtD
Leucovorin—Asthenia—Vincristine—colon cancer	6.68e-05	0.00352	CcSEcCtD
Leucovorin—Syncope—Capecitabine—colon cancer	6.67e-05	0.00351	CcSEcCtD
Leucovorin—Leukopenia—Capecitabine—colon cancer	6.65e-05	0.0035	CcSEcCtD
Leucovorin—Loss of consciousness—Capecitabine—colon cancer	6.53e-05	0.00344	CcSEcCtD
Leucovorin—Asthenia—Irinotecan—colon cancer	6.5e-05	0.00342	CcSEcCtD
Leucovorin—Hypersensitivity—Fluorouracil—colon cancer	6.4e-05	0.00337	CcSEcCtD
Leucovorin—Diarrhoea—Vincristine—colon cancer	6.37e-05	0.00335	CcSEcCtD
Leucovorin—Discomfort—Capecitabine—colon cancer	6.25e-05	0.00329	CcSEcCtD
Leucovorin—Diarrhoea—Irinotecan—colon cancer	6.2e-05	0.00327	CcSEcCtD
Leucovorin—Dizziness—Vincristine—colon cancer	6.15e-05	0.00324	CcSEcCtD
Leucovorin—Pruritus—Fluorouracil—colon cancer	6.14e-05	0.00323	CcSEcCtD
Leucovorin—Confusional state—Capecitabine—colon cancer	6.12e-05	0.00322	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	6.05e-05	0.015	CbGpPWpGaD
Leucovorin—Infection—Capecitabine—colon cancer	6.03e-05	0.00317	CcSEcCtD
Leucovorin—Dizziness—Irinotecan—colon cancer	5.99e-05	0.00316	CcSEcCtD
Leucovorin—Shock—Capecitabine—colon cancer	5.97e-05	0.00314	CcSEcCtD
Leucovorin—Diarrhoea—Fluorouracil—colon cancer	5.94e-05	0.00313	CcSEcCtD
Leucovorin—Thrombocytopenia—Capecitabine—colon cancer	5.94e-05	0.00313	CcSEcCtD
Leucovorin—Vomiting—Vincristine—colon cancer	5.92e-05	0.00312	CcSEcCtD
Leucovorin—Skin disorder—Capecitabine—colon cancer	5.89e-05	0.0031	CcSEcCtD
Leucovorin—Rash—Vincristine—colon cancer	5.87e-05	0.00309	CcSEcCtD
Leucovorin—Dermatitis—Vincristine—colon cancer	5.86e-05	0.00309	CcSEcCtD
Leucovorin—Anorexia—Capecitabine—colon cancer	5.78e-05	0.00304	CcSEcCtD
Leucovorin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	5.78e-05	0.0143	CbGpPWpGaD
Leucovorin—Vomiting—Irinotecan—colon cancer	5.76e-05	0.00303	CcSEcCtD
Leucovorin—Dizziness—Fluorouracil—colon cancer	5.74e-05	0.00302	CcSEcCtD
Leucovorin—Rash—Irinotecan—colon cancer	5.71e-05	0.00301	CcSEcCtD
Leucovorin—Dermatitis—Irinotecan—colon cancer	5.71e-05	0.00301	CcSEcCtD
Leucovorin—Chills—Methotrexate—colon cancer	5.7e-05	0.003	CcSEcCtD
Leucovorin—Alopecia—Methotrexate—colon cancer	5.62e-05	0.00296	CcSEcCtD
Leucovorin—Erythema—Methotrexate—colon cancer	5.53e-05	0.00291	CcSEcCtD
Leucovorin—Nausea—Vincristine—colon cancer	5.53e-05	0.00291	CcSEcCtD
Leucovorin—Vomiting—Fluorouracil—colon cancer	5.52e-05	0.00291	CcSEcCtD
Leucovorin—Rash—Fluorouracil—colon cancer	5.47e-05	0.00288	CcSEcCtD
Leucovorin—Dermatitis—Fluorouracil—colon cancer	5.47e-05	0.00288	CcSEcCtD
Leucovorin—Dysgeusia—Methotrexate—colon cancer	5.42e-05	0.00285	CcSEcCtD
Leucovorin—Dyspnoea—Capecitabine—colon cancer	5.41e-05	0.00285	CcSEcCtD
Leucovorin—Nausea—Irinotecan—colon cancer	5.38e-05	0.00283	CcSEcCtD
Leucovorin—Dyspepsia—Capecitabine—colon cancer	5.34e-05	0.00281	CcSEcCtD
Leucovorin—Decreased appetite—Capecitabine—colon cancer	5.27e-05	0.00278	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Capecitabine—colon cancer	5.24e-05	0.00276	CcSEcCtD
Leucovorin—Fatigue—Capecitabine—colon cancer	5.23e-05	0.00275	CcSEcCtD
Leucovorin—Constipation—Capecitabine—colon cancer	5.19e-05	0.00273	CcSEcCtD
Leucovorin—Nausea—Fluorouracil—colon cancer	5.16e-05	0.00272	CcSEcCtD
Leucovorin—Ill-defined disorder—Methotrexate—colon cancer	5.13e-05	0.0027	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	5.1e-05	0.0127	CbGpPWpGaD
Leucovorin—Feeling abnormal—Capecitabine—colon cancer	5e-05	0.00263	CcSEcCtD
Leucovorin—Malaise—Methotrexate—colon cancer	4.99e-05	0.00263	CcSEcCtD
Leucovorin—Gastrointestinal pain—Capecitabine—colon cancer	4.96e-05	0.00261	CcSEcCtD
Leucovorin—Leukopenia—Methotrexate—colon cancer	4.95e-05	0.00261	CcSEcCtD
Leucovorin—Methotrexate—ABCB1—colon cancer	4.93e-05	0.0304	CrCbGaD
Leucovorin—Urticaria—Capecitabine—colon cancer	4.82e-05	0.00254	CcSEcCtD
Leucovorin—Body temperature increased—Capecitabine—colon cancer	4.8e-05	0.00253	CcSEcCtD
Leucovorin—Abdominal pain—Capecitabine—colon cancer	4.8e-05	0.00253	CcSEcCtD
Leucovorin—Convulsion—Methotrexate—colon cancer	4.79e-05	0.00252	CcSEcCtD
Leucovorin—TYMS—Cell Cycle—MLH3—colon cancer	4.71e-05	0.0117	CbGpPWpGaD
Leucovorin—Discomfort—Methotrexate—colon cancer	4.65e-05	0.00245	CcSEcCtD
Leucovorin—Confusional state—Methotrexate—colon cancer	4.55e-05	0.0024	CcSEcCtD
Leucovorin—Anaphylactic shock—Methotrexate—colon cancer	4.52e-05	0.00238	CcSEcCtD
Leucovorin—Infection—Methotrexate—colon cancer	4.49e-05	0.00236	CcSEcCtD
Leucovorin—Hypersensitivity—Capecitabine—colon cancer	4.47e-05	0.00235	CcSEcCtD
Leucovorin—Thrombocytopenia—Methotrexate—colon cancer	4.42e-05	0.00233	CcSEcCtD
Leucovorin—Skin disorder—Methotrexate—colon cancer	4.39e-05	0.00231	CcSEcCtD
Leucovorin—Asthenia—Capecitabine—colon cancer	4.35e-05	0.00229	CcSEcCtD
Leucovorin—Anorexia—Methotrexate—colon cancer	4.3e-05	0.00227	CcSEcCtD
Leucovorin—Pruritus—Capecitabine—colon cancer	4.29e-05	0.00226	CcSEcCtD
Leucovorin—TYMS—Fluoropyrimidine Activity—TP53—colon cancer	4.22e-05	0.0105	CbGpPWpGaD
Leucovorin—Diarrhoea—Capecitabine—colon cancer	4.15e-05	0.00219	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	4.07e-05	0.0101	CbGpPWpGaD
Leucovorin—Dyspnoea—Methotrexate—colon cancer	4.03e-05	0.00212	CcSEcCtD
Leucovorin—Dizziness—Capecitabine—colon cancer	4.01e-05	0.00211	CcSEcCtD
Leucovorin—Dyspepsia—Methotrexate—colon cancer	3.97e-05	0.00209	CcSEcCtD
Leucovorin—Decreased appetite—Methotrexate—colon cancer	3.93e-05	0.00207	CcSEcCtD
Leucovorin—Gastrointestinal disorder—Methotrexate—colon cancer	3.9e-05	0.00205	CcSEcCtD
Leucovorin—Fatigue—Methotrexate—colon cancer	3.89e-05	0.00205	CcSEcCtD
Leucovorin—Vomiting—Capecitabine—colon cancer	3.86e-05	0.00203	CcSEcCtD
Leucovorin—Rash—Capecitabine—colon cancer	3.82e-05	0.00201	CcSEcCtD
Leucovorin—Dermatitis—Capecitabine—colon cancer	3.82e-05	0.00201	CcSEcCtD
Leucovorin—Feeling abnormal—Methotrexate—colon cancer	3.72e-05	0.00196	CcSEcCtD
Leucovorin—TYMS—Metabolism—CA7—colon cancer	3.69e-05	0.00917	CbGpPWpGaD
Leucovorin—Gastrointestinal pain—Methotrexate—colon cancer	3.69e-05	0.00194	CcSEcCtD
Leucovorin—Nausea—Capecitabine—colon cancer	3.6e-05	0.0019	CcSEcCtD
Leucovorin—Urticaria—Methotrexate—colon cancer	3.59e-05	0.00189	CcSEcCtD
Leucovorin—Abdominal pain—Methotrexate—colon cancer	3.57e-05	0.00188	CcSEcCtD
Leucovorin—Body temperature increased—Methotrexate—colon cancer	3.57e-05	0.00188	CcSEcCtD
Leucovorin—ABCC3—Fluoropyrimidine Activity—TP53—colon cancer	3.49e-05	0.00868	CbGpPWpGaD
Leucovorin—Hypersensitivity—Methotrexate—colon cancer	3.33e-05	0.00175	CcSEcCtD
Leucovorin—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	3.28e-05	0.00816	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—CDKN1A—colon cancer	3.28e-05	0.00816	CbGpPWpGaD
Leucovorin—Asthenia—Methotrexate—colon cancer	3.24e-05	0.00171	CcSEcCtD
Leucovorin—Pruritus—Methotrexate—colon cancer	3.19e-05	0.00168	CcSEcCtD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	3.18e-05	0.0079	CbGpPWpGaD
Leucovorin—TYMS—E2F transcription factor network—EP300—colon cancer	3.12e-05	0.00776	CbGpPWpGaD
Leucovorin—Diarrhoea—Methotrexate—colon cancer	3.09e-05	0.00163	CcSEcCtD
Leucovorin—ABCC3—Metabolism—CA7—colon cancer	3.06e-05	0.00759	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	3.01e-05	0.00747	CbGpPWpGaD
Leucovorin—Dizziness—Methotrexate—colon cancer	2.99e-05	0.00157	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CCND1—colon cancer	2.95e-05	0.00733	CbGpPWpGaD
Leucovorin—Vomiting—Methotrexate—colon cancer	2.87e-05	0.00151	CcSEcCtD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—CDKN1A—colon cancer	2.85e-05	0.00709	CbGpPWpGaD
Leucovorin—Rash—Methotrexate—colon cancer	2.85e-05	0.0015	CcSEcCtD
Leucovorin—Dermatitis—Methotrexate—colon cancer	2.84e-05	0.0015	CcSEcCtD
Leucovorin—TYMS—E2F transcription factor network—MYC—colon cancer	2.72e-05	0.00676	CbGpPWpGaD
Leucovorin—Nausea—Methotrexate—colon cancer	2.68e-05	0.00141	CcSEcCtD
Leucovorin—TYMS—G1/S Transition—CDKN1A—colon cancer	2.38e-05	0.00592	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—MYC—colon cancer	2.37e-05	0.00588	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—APC—colon cancer	2.29e-05	0.00569	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—CHST5—colon cancer	2.24e-05	0.00556	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ODC1—colon cancer	2.24e-05	0.00556	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—VEGFA—colon cancer	2.14e-05	0.00532	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—PPARG—colon cancer	2.12e-05	0.00528	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CCND1—colon cancer	2.08e-05	0.00516	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MLH1—colon cancer	2.07e-05	0.00515	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.04e-05	0.00506	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—CDKN1A—colon cancer	2.01e-05	0.00499	CbGpPWpGaD
Leucovorin—TYMS—G1/S Transition—MYC—colon cancer	1.98e-05	0.00491	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—BUB1B—colon cancer	1.97e-05	0.0049	CbGpPWpGaD
Leucovorin—ABCC4—Platelet degranulation—TGFB1—colon cancer	1.96e-05	0.00488	CbGpPWpGaD
Leucovorin—TYMS—Retinoblastoma (RB) in Cancer—TP53—colon cancer	1.94e-05	0.00483	CbGpPWpGaD
Leucovorin—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.87e-05	0.00465	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—CHST5—colon cancer	1.85e-05	0.0046	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ODC1—colon cancer	1.85e-05	0.0046	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—BUB1B—colon cancer	1.76e-05	0.00438	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	1.74e-05	0.00432	CbGpPWpGaD
Leucovorin—TYMS—Mitotic G1-G1/S phases—MYC—colon cancer	1.67e-05	0.00414	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	1.62e-05	0.00401	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	1.57e-05	0.00391	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	1.57e-05	0.0039	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	1.56e-05	0.00387	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	1.52e-05	0.00378	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.45e-05	0.0036	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.41e-05	0.0035	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—EP300—colon cancer	1.39e-05	0.00345	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.37e-05	0.0034	CbGpPWpGaD
Leucovorin—ABCC3—NRF2 pathway—TGFB1—colon cancer	1.29e-05	0.00321	CbGpPWpGaD
Leucovorin—ABCC4—Ectoderm Differentiation—MYC—colon cancer	1.27e-05	0.00316	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.26e-05	0.00313	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.26e-05	0.00313	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.23e-05	0.00306	CbGpPWpGaD
Leucovorin—ABCC4—NRF2 pathway—TGFB1—colon cancer	1.21e-05	0.00302	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.17e-05	0.00289	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.07e-05	0.00266	CbGpPWpGaD
Leucovorin—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.05e-05	0.0026	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.04e-05	0.00257	CbGpPWpGaD
Leucovorin—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.02e-05	0.00254	CbGpPWpGaD
Leucovorin—TYMS—Circadian rythm related genes—TP53—colon cancer	9.95e-06	0.00247	CbGpPWpGaD
Leucovorin—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	9.83e-06	0.00244	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	9.75e-06	0.00242	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	9.49e-06	0.00236	CbGpPWpGaD
Leucovorin—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	8.75e-06	0.00217	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	8.71e-06	0.00216	CbGpPWpGaD
Leucovorin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	8.29e-06	0.00206	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.65e-06	0.0019	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CCND1—colon cancer	7.61e-06	0.00189	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	7.42e-06	0.00184	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—CDKN1A—colon cancer	7.37e-06	0.00183	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—EP300—colon cancer	7.01e-06	0.00174	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CCND1—colon cancer	6.81e-06	0.00169	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—CDKN1A—colon cancer	6.59e-06	0.00164	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—EP300—colon cancer	6.27e-06	0.00156	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle, Mitotic—MYC—colon cancer	6.11e-06	0.00152	CbGpPWpGaD
Leucovorin—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	6.06e-06	0.0015	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.02e-06	0.00149	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—ABCB1—colon cancer	5.91e-06	0.00147	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—MYC—colon cancer	5.46e-06	0.00136	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—EP300—colon cancer	5.17e-06	0.00128	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—SRC—colon cancer	5.02e-06	0.00125	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	5e-06	0.00124	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—ABCB1—colon cancer	4.9e-06	0.00122	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—VEGFA—colon cancer	4.89e-06	0.00122	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—NRAS—colon cancer	4.83e-06	0.0012	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—TYMS—colon cancer	4.81e-06	0.00119	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TGFB1—colon cancer	4.49e-06	0.00112	CbGpPWpGaD
Leucovorin—TYMS—Cell Cycle—TP53—colon cancer	4.48e-06	0.00111	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—KRAS—colon cancer	4.16e-06	0.00103	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PPARG—colon cancer	4.11e-06	0.00102	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—PIK3CA—colon cancer	3.82e-06	0.000949	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.7e-06	0.000919	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—TP53—colon cancer	3.7e-06	0.000918	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—HRAS—colon cancer	3.54e-06	0.000878	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PPARG—colon cancer	3.41e-06	0.000846	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PTGS2—colon cancer	3.24e-06	0.000804	CbGpPWpGaD
Leucovorin—ABCC4—Hemostasis—AKT1—colon cancer	3.12e-06	0.000775	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—EP300—colon cancer	2.69e-06	0.000669	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PTGS2—colon cancer	2.68e-06	0.000665	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—EP300—colon cancer	2.23e-06	0.000553	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—PIK3CA—colon cancer	1.99e-06	0.000495	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—PIK3CA—colon cancer	1.65e-06	0.000409	CbGpPWpGaD
Leucovorin—TYMS—Metabolism—AKT1—colon cancer	1.63e-06	0.000404	CbGpPWpGaD
Leucovorin—ABCC3—Metabolism—AKT1—colon cancer	1.35e-06	0.000334	CbGpPWpGaD
